New nanoparticle approach targets cancer cells with precision drug delivery

Researchers have developed a nanotechnology platform that uses glutathione-scavenging particles to deliver cancer-fighting proteins directly to tumor cells, potentially improving treatment effectiveness while reducing side effects. The advance could accelerate development of next-generation cancer therapies and create commercial opportunities in precision oncology.

Originaltitel: Glutathione-Scavenging Nanoparticle-Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects